Valveclip® Transcatheter Mitral Valve Repair Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT05021614

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05021614
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05021614. Allocation not applicable; no masking; primary purpose treatment. Start 2021-09-24 (actual); primary completion 2024-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Valveclip® Transcatheter Mitral Valve Repair Study
Condition
Mitral Regurgitation
Intervention (Device)
Valveclip® Transcatheter mitral valve repair
Lead sponsor
Shanghai NewMed Medical Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05021614
Content hash
ae7c6fcd37f4728bd313656810977ab570b4c87a99fc049420c0b27d634cb7f0